Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siming Li

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer|April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral MelanomaJie Dai, Lu Yang, Tianxiao Xu, et al.
Ebiomedicine|April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinomaXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Innovation (Cambridge (Mass.))|June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinomaChuanliang Cui, Juan Li, Yue Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-IIIYang Wang, Bin Lian, Lu Si, et al.
Science Translational Medicine|March 13, 2024
Hepatic danger signaling triggers TREM2<sup>+</sup> macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activationLinkang Zhou, Xiaoxue Qiu, Ziyi Meng, et al.
BMC Cancer|May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I studyLi Zhou, Xiaowen Wu, Zhihong Chi, et al.
Science Advances|May 15, 2024
Molecular beacon-based detection of circulating microRNA-containing extracellular vesicle as an α-synucleinopathy biomarkerZhenwei Yu, Yuanchu Zheng, Huihui Cai, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer|April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral MelanomaJie Dai, Lu Yang, Tianxiao Xu, et al.
Ebiomedicine|April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinomaXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Innovation (Cambridge (Mass.))|June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinomaChuanliang Cui, Juan Li, Yue Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-IIIYang Wang, Bin Lian, Lu Si, et al.
Science Translational Medicine|March 13, 2024
Hepatic danger signaling triggers TREM2<sup>+</sup> macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activationLinkang Zhou, Xiaoxue Qiu, Ziyi Meng, et al.
BMC Cancer|May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I studyLi Zhou, Xiaowen Wu, Zhihong Chi, et al.
Science Advances|May 15, 2024
Molecular beacon-based detection of circulating microRNA-containing extracellular vesicle as an α-synucleinopathy biomarkerZhenwei Yu, Yuanchu Zheng, Huihui Cai, et al.
Pageof 25